These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 15823902

  • 1. Selective persistence of dermal CD8+ T cells in lesional plaque psoriasis after clobetasol-17 propionate treatment.
    Bovenschen HJ, Vissers WH, Seyger MM, van de Kerkhof PC.
    Acta Derm Venereol; 2005; 85(2):113-7. PubMed ID: 15823902
    [Abstract] [Full Text] [Related]

  • 2. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Bovenschen HJ, Seyger MM, Van de Kerkhof PC.
    Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
    [Abstract] [Full Text] [Related]

  • 3. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis.
    Vissers WH, Berends M, Muys L, van Erp PE, de Jong EM, van de Kerkhof PC.
    Exp Dermatol; 2004 Feb; 13(2):106-12. PubMed ID: 15009104
    [Abstract] [Full Text] [Related]

  • 4. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
    Bovenschen HJ, Erceg A, Van Vlijmen-Willems I, Van De Kerkhof PC, Seyger MM.
    J Dermatolog Treat; 2007 Feb; 18(1):32-9. PubMed ID: 17365265
    [Abstract] [Full Text] [Related]

  • 5. Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression.
    Vissers WH, van Vlijmen I, van Erp PE, de Jong EM, van de Kerkhof PC.
    Br J Dermatol; 2008 Apr; 158(4):705-12. PubMed ID: 18284400
    [Abstract] [Full Text] [Related]

  • 6. Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis.
    Bovenschen HJ, Gerritsen WJ, van Rens DW, Seyger MM, de Jong EM, van de Kerkhof PC.
    Arch Dermatol Res; 2007 Feb; 298(9):457-63. PubMed ID: 17136563
    [Abstract] [Full Text] [Related]

  • 7. Flexural versus plaque lesions in psoriasis: an immunohistochemical differentiation.
    Vissers WH, Roelofzen J, De Jong EM, Van Erp PE, Van de Kerkhof PC.
    Eur J Dermatol; 2005 Feb; 15(1):13-7. PubMed ID: 15701587
    [Abstract] [Full Text] [Related]

  • 8. Dimethylfumarate for psoriasis: Pronounced effects on lesional T-cell subsets, epidermal proliferation and differentiation, but not on natural killer T cells in immunohistochemical study.
    Bovenschen HJ, Langewouters AM, van de Kerkhof PC.
    Am J Clin Dermatol; 2010 Feb; 11(5):343-50. PubMed ID: 20553063
    [Abstract] [Full Text] [Related]

  • 9. Combination of calcipotriol and clobetasol propionate as a premixed ointment for the treatment of psoriasis.
    Katoh N, Kishimoto S.
    Eur J Dermatol; 2003 Feb; 13(4):382-4. PubMed ID: 12948920
    [Abstract] [Full Text] [Related]

  • 10. Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late.
    Vissers WH, Arndtz CH, Muys L, Van Erp PE, de Jong EM, van de Kerkhof PC.
    Br J Dermatol; 2004 May; 150(5):852-9. PubMed ID: 15149496
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.
    Swinkels OQ, Prins M, Tosserams EF, Gerritsen MJ, Van Der Valk PG, Van De Kerkhof PC.
    Br J Dermatol; 2001 Jul; 145(1):63-9. PubMed ID: 11453908
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical differentiation between inflammatory linear verrucous epidermal nevus (ILVEN) and psoriasis.
    Vissers WH, Muys L, Erp PE, de Jong EM, van de Kerkhof PC.
    Eur J Dermatol; 2004 Jul; 14(4):216-20. PubMed ID: 15319153
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis.
    Jarratt MT, Clark SD, Savin RC, Swinyer LJ, Safley CF, Brodell RT, Yu K.
    Cutis; 2006 Nov; 78(5):348-54. PubMed ID: 17186795
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A multi-center, open-label study to evaluate the safety and efficacy of a sequential treatment regimen of clobetasol propionate 0.05% spray followed by Calcitriol 3 mg/g ointment in the management of plaque psoriasis.
    Brodell RT, Bruce S, Hudson CP, Weiss JS, Colón LE, Johnson LA, Gottschalk RW.
    J Drugs Dermatol; 2011 Feb; 10(2):158-64. PubMed ID: 21283920
    [Abstract] [Full Text] [Related]

  • 19. Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment.
    Sánchez Regaña M, Márquez Balbás G, Umbert Millet P.
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):963-9. PubMed ID: 18410337
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.